DIA426.28+3.47 0.82%
SPX6,033.11+56.14 0.94%
IXIC19,701.21+294.39 1.52%

Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?

Barchart·06/06/2025 09:30:21
Listen to the news

Canada-based Village Farms International VFF has staged a strong rally this year, all thanks to a significant strategic decision aimed at reshaping its business focus.

Last month, Village Farms announced a bold pivot — it decided to divest its fresh-produce business, aiming to reestablish itself as a pure-play cannabis operator. The transaction was closed swiftly on May 30.

Let’s delve into the company’s fundamentals to gain a better understanding of how to play the stock after this divestiture decision.

VFF Goes All in on Cannabis

Village Farms officially closed the divestiture of its fresh produce business last week, transferring those assets to Vanguard Food LP — a joint venture backed by private investment firms. Per VFF, the transaction enables it to solidify its identity as a pure-play cannabis company, with about 160 acres of advanced greenhouse facilities. As part of the deal, the company received $40 million in cash and retained a 37.9% equity stake in Vanguard.

The divestiture decision comes amid strong recent performance in VFF’s cannabis segment. Though the produce business accounted for about half of Village Farms’ topline, the segment operated on thinner margins and faced persistent operational headwinds.

In the first quarter of fiscal 2025, sales of Village Farms’ fresh produce business rose 4% year over year to $37.4 million. However, dust storms in March and April led to a significant margin squeeze, resulting in a segment net loss of $7.8 million — a sharp decline from a near-breakeven result in the year-ago period. This underperformance was the main reason behind the company’s consolidated net loss.

Meanwhile, the cannabis segment told a very different story. International medical cannabis exports surged 285% year over year, driven by higher shipment volumes to key markets like Australia, Germany, and the U.K. This contributed to a 258% spike in net income for VFF’s Canadian cannabis business, which reached $3 million. The segment’s gross margin also expanded to 36%, reflecting improved pricing power and greater operating leverage.

Village Farms retained its position as one of Canada’s top three cannabis players, even while trimming lower-margin products from its retail portfolio. The company also began commercial shipments to the Netherlands in early 2025, adding $0.5 million in incremental revenues.

Looking ahead, management expects international medical cannabis sales to triple in fiscal 2025, providing further support to the company’s transformation story. The global medical cannabis market is projected to surpass the $130 billion mark by the end of 2032, primarily driven by the increasing acceptance of cannabis for therapeutic purposes.

Other Players in the Cannabis Space

Village Farms operates in a highly competitive market. It faces stiff competition from its peers like Aurora Cannabis ACB, Canopy Growth CGC and Tilray Brands TLRY. ACB, CGC and TLRY are also pursuing international expansion and cost optimization strategies, making the competitive landscape even tougher.

As Village Farms gains traction in international markets — especially in Europe and Australia — it is likely to draw more attention from Aurora Cannabis, Canopy Growth and Tilray Brands. This competitive pressure may spur more aggressive strategies from its peers, potentially accelerating sector consolidation.

VFF Stock Performance and Estimates

Shares of Village Farms have soared 61% year to date against the industry’s 1% decline, as seen in the chart below.

Zacks Investment Research
Image Source: Zacks Investment Research

EPS estimates for fiscal 2025 and 2026 have seen mixed revisions over the past 60 days.

Zacks Investment Research
Image Source: Zacks Investment Research

How to Play VFF Stock?

While Village Farms' decisive pivot to a cannabis-first strategy is a compelling narrative that has rightly captured investor attention. Investors may want to hold off on initiating or expanding positions until greater earnings visibility emerges over the coming quarters. Existing shareholders may consider maintaining their positions while closely tracking this Zacks Rank #3 (Hold) company’s quarterly execution.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Canopy Growth Corporation (CGC): Free Stock Analysis Report
 
Tilray Brands, Inc. (TLRY): Free Stock Analysis Report
 
Aurora Cannabis Inc. (ACB): Free Stock Analysis Report
 
Village Farms International, Inc. (VFF): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.